Daniel P. O'Day - Mar 10, 2025 Form 4 Insider Report for GILEAD SCIENCES, INC. (GILD)

Role: Chairman & CEO, Director
Signature: /s/ Edward S. Son by Power of Attorney for Daniel P. O'Day
Stock symbol: GILD
Transactions as of: Mar 10, 2025
Transactions value $: -$1,363,387
Form type: 4
Date filed: 3/12/2025, 07:12 PM
Previous filing: Feb 6, 2025
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	GILD	Common Stock	Options Exercise		+24K	+3.89%		642K	Mar 10, 2025	Direct	F1
transaction	GILD	Common Stock	Tax liability	-$1.36M	-11.6K	-1.81%	$117.21	630K	Mar 10, 2025	Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	GILD	Restricted Stock Unit	Options Exercise		-24K	-22.89%		81K	Mar 10, 2025	Common Stock	24K		Direct	F1, F2
transaction	GILD	Non-qualified Stock Option (Right to Buy)	Award	$0	+170K		$0.00	170K	Mar 10, 2025	Common Stock	170K	$117.21	Direct	F3
transaction	GILD	Restricted Stock Unit	Award		+38.4K	+47.43%		119K	Mar 10, 2025	Common Stock	38.4K		Direct	F1, F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock.
F2	The restricted stock units have a four-year vesting schedule. 25% vest on the first anniversary of the date of the grant. The balance will vest 6.25% quarterly thereafter until fully vested.
F3	The options have a four-year vesting schedule. 25% of the options will vest on the first anniversary date of the grant. The balance will vest 6.25% quarterly thereafter until fully vested.